Reclassifying bioterrorism risk: Are we preparing for the proper pathogens?

Journal of Infection and Public Health

Volumn 2, Issue 2, 2009, Pages 55-61

  Pappas, Georgios ^a   Panagopoulou, Paraskevi ^a   Akritidis, Nikolaos ^b  

^a Institute of Continuing Medical Education of Ioannina   (Greece)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

Author keywords

Bioterrorism; Classification; Risk

Indexed keywords

ANTHRAX; AVIAN INFLUENZA; BIOLOGICAL WARFARE; EBOLA VIRUS; FILOVIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS TRANSMISSION;

BIOLOGICAL WARFARE AGENTS; BIOTERRORISM; BLOOD-BORNE PATHOGENS; DISASTER PLANNING; HUMANS; RISK; RISK ASSESSMENT;

EID: 67349256394     PISSN: 18760341     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jiph.2009.03.002     Document Type: Review

References (44)

1. Cunha B.A. The cause of the plague of Athens: plague, typhoid, typhus, smallpox, or measles?. Infect Dis Clin North Am 18 (2004) 29-43
2. Christopher G.W., Cieslak T.J., Pavlin J.A., and Eitzen Jr. E.M. Biological warfare. A historical perspective. JAMA 278 (1997) 412-417
3. Roffey R., Tegnell A., and Elgh F. Biological warfare in a historical perspective. Clin Microbiol Infect 8 (2002) 450-454
4. Dembek Z., Iton A., and Hansen H. A model curriculum for public health bioterrorism education. Public Health Rep 120 (2005) 11-18
5. Helget V., and Smith P.W. Bioterrorism preparedness: a survey of Nebraska health care institutions. Am J Infect Control 30 (2002) 46-48
6. Henderson D.A. The looming threat of bioterrorism. Science 283 (1999) 1279-1282
7. Khan A.S., and Ashford D.A. Ready or not-preparedness for bioterrorism. N Engl J Med 345 (2001) 287-289
8. Markenson D., Dimaggio C., and Redlener I. Preparing health professions students for terrorism, disaster, and public health emergencies: core competencies. Acad Med 80 (2005) 517-526
9. Klietmann W.F., and Ruoff K.L. Bioterrorism: implications for the clinical microbiologist. Clin Microbiol Rev 14 (2001) 364-381
10. Inglesby T.V., Grossman R., and O'Toole T. A plague on your city: observations from TOPOFF. Clin Infect Dis 32 (2001) 436-445
11. Centers for Disease Control and Prevention. Emergency Preparedness and Response. Bioterrorism Agents/ Diseases. Available at http://www.bt.cdc.gov/agent/agentlist.asp, last accessed March 23, 2009.
12. World Health Organization. Public health response to biological and chemical weapons: WHO guidance (2004). Available at http://www.who.int/csr/delibepidemics/biochemguide/en/index.html, last accessed March 23, 2009.
13. NATO Handbook on the medical aspects of NBC defensive operations. AMed-P6(B). Available at http://www.fas.org/nuke/guide/usa/doctrine/dod/fm8-9/2toc.htm, last accessed March 23, 2009.
14. National Institute of Allergy and Infectious Diseases. Biodefense. NIAID Category A, B, and C Priority Pathogens. Available at http://www3.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/research/CatA.htm, last accessed March 23, 2009.
15. Barnett D.J., Balicer R.D., Blodgett D., Fews A.L., Parker C.L., and Links J.M. The application of the Haddon matrix to public health readiness and response planning. Environ Health Perspect 113 (2005) 561-566
16. Barnett D.J., Balicer R.D., Lucey D.R., Everly G.S., Omer S.B., Steinhoff M.C., et al. A systematic analytic approach to pandemic influenza preparedness planning. PLoS Med 2 (2005) e359
17. Madariaga M.G., Rezai K., Trenholme G.M., and Weinstein R.A. Q fever: a biological weapon in your backyard. Lancet Infect Dis 3 (2003) 709-721
18. Dennis D.T., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Tularemia as a biological weapon: medical and public health management. JAMA 285 (2001) 2763-2773
19. Raoult D., Woodward T., and Dumler J.S. The history of epidemic typhus. Infect Dis Clin North Am 18 (2004) 127-140
20. O'Toole T. Smallpox: an attack scenario. Emerg Infect Dis 5 (1999) 540-546
21. Smith B.T., Inglesby T.V., Brimmer E., Borio L., Franco C., Gronvall G.K., et al. Navigating the storm: report and recommendations from the Atlantic Storm exercise. Biosecur Bioterror 3 (2005) 256-267
22. Rubinson L., Nuzzo J.B., Talmor D.S., O'Toole T., Kramer B.R., and Inglesby T.V. Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: recommendations of the working group on emergency mass critical care. Crit Care Med 33 (2005) 2393-2403
23. Casadevall A., and Pirofski L.A. The weapon potential of a microbe. Trends Microbiol 12 (2004) 259-263
24. Pappas G., Panagopoulou P., Christou L., and Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 63 (2006) 2229-2236
25. Maltezou H.C. Nosocomial influenza: new concepts and practice. Curr Opin Infect Dis 21 (2008) 337-343
26. Seward J.F., Galil K., Damon I., Norton S.A., Rotz L., Schmid S., et al. Development and experience with an algorithm to evaluate suspected smallpox cases in the United States 2002-2004. Clin Infect Dis 39 (2004) 1477-1483
27. Swartz M.N. Recognition and management of anthrax-an update. N Engl J Med 345 (2001) 1621-1626
28. Willis E.A. Contamination compensation: gruinard as a menace to the mainland. Med Confl Surviv 20 (2004) 334-343
29. Cupp O.S., Walker II D.E., and Hillison J. Agroterrorism in the US: key security challenge for the 21st century. Biosecur Bioterror 2 (2004) 97-105
30. Rotz L.D., Khan A.S., Lillibridge S.R., Ostroff S.M., and Hughes J.M. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 8 (2002) 225-230
31. Pappas G., Seitaridis S., Akritidis N., and Tsianos E. Infectious diseases in cinema: virus hunters and killer microbes. Clin Infect Dis 37 (2003) 939-942
32. Beigel J.H., Farrar J., Han A.M., Hayden F.G., Hyer R., de Jong M.D., et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 353 (2005) 1374-1385
33. Pappas G., Akritidis N., and Tsianos E.V. Attack scenarios with rickettsial species-implications for response and management. Ann NY Acad Sci 1063 (2005) 451-458
34. Cosgrove S.E., Perl T.M., Song X., and Sisson S.D. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Arch Intern Med 165 (2005) 2002-2006
35. Mullin S. Public health and the media: the challenge now faced by bioterrorism. J Urban Health 79 (2002) 12
36. Glass T.A., and Schoch-Spana M. Bioterrorism and the people: how to vaccinate a city against panic. Clin Infect Dis 34 (2002) 217-223
37. Leavitt J.W. Public resistance or cooperation? A tale of smallpox in two cities. Biosecur Bioterror 1 (2003) 185-192
38. Dougall A.L., Hayward M.C., and Baum A. Media exposure to bioterrorism: stress and the anthrax attacks. Psychiatry 68 (2005) 28-42
39. Rubin G.J., Brewin C.R., Greenberg N., Simpson J., and Wessely S. Psychological and behavioural reactions to the bombings in London on 7 July 2005: cross sectional survey of a representative sample of Londoners. BMJ 331 (2005) 606
40. Kark J.D., Goldman S., and Epstein L. Iraqi missile attacks on Israel. The association of mortality with a life-threatening stressor. JAMA 273 (1995) 1208-1210
41. Hodge Jr. J.G., Gable L.A., and Calves S.H. Volunteer health professionals and emergencies: assessing and transforming the legal environment. Biosecur Bioterror 3 (2005) 216-223
42. Annas G.J. Bioterrorism, public health, and civil liberties. N Engl J Med 346 (2002) 1337-1342
43. Relman D.A. Bioterrorism-preparing to fight the next war. N Engl J Med 354 (2006) 113-115
44. Blendon R.J., DesRoches C.M., Benson J.M., Herrmann M.J., Taylor-Clark K., and Weldon K.J. The public and the smallpox threat. N Engl J Med 348 (2003) 426-432